{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:07:01Z","timestamp":1788984421142,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.mcp.2022.101833","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T22:06:19Z","timestamp":1654812379000},"page":"101833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Robust humoral immune response against rabies virus in rabbits and guinea pigs immunized with plasmid DNA vectors encoding rabies virus glycoproteins \u2013 An approach to the production of polyclonal antibody reagents"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3363-8361","authenticated-orcid":false,"given":"Dmitriy V.","family":"Volokhov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyacheslav","family":"Furtak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayle","family":"Pulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle D.","family":"Zajac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yotam","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Kochba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcp.2022.101833_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2016.08.012","article-title":"Rabies vaccination in dogs using a dissolving microneedle patch","volume":"239","author":"Arya","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mcp.2022.101833_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0264-410X(97)00204-1","article-title":"DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses","volume":"16","author":"Bahloul","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101833_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0264-410X(03)00568-1","article-title":"Post-exposure therapy in mice against experimental rabies: a single injection of DNA vaccine is as effective as five injections of cell culture-derived vaccine","volume":"22","author":"Bahloul","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101833_bib4","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1089\/104303401753153965","article-title":"Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine","volume":"12","author":"Biswas","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mcp.2022.101833_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/vaccines1030305","article-title":"Optimization of HIV-1 envelope DNA vaccine candidates within three different animal models, guinea pigs, rabbits and cynomolgus macaques","volume":"1","author":"Borggren","year":"2013","journal-title":"Vaccines"},{"key":"10.1016\/j.mcp.2022.101833_bib6","doi-asserted-by":"crossref","first-page":"e839","DOI":"10.1371\/journal.pntd.0000839","article-title":"Rabies, still neglected after 125 years of vaccination","volume":"4","author":"Bourhy","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.mcp.2022.101833_bib7","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3390\/v13071252","article-title":"The route of administration of rabies vaccines: comparing the data","volume":"13","author":"Briggs","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.mcp.2022.101833_bib8","series-title":"Rabies: Scientific Basis of the Disease and its Management","first-page":"445","article-title":"Measures of rabies immunity","author":"Moore","year":"2020"},{"key":"10.1016\/j.mcp.2022.101833_bib9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S1473-3099(19)30311-1","article-title":"A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study","volume":"19","author":"Cantaert","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mcp.2022.101833_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biologicals.2017.02.002","article-title":"G-protein based ELISA as a potency test for rabies vaccines","volume":"46","author":"Chabaud-Riou","year":"2017","journal-title":"Biologicals"},{"key":"10.1016\/j.mcp.2022.101833_bib11","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/v11121118","article-title":"Monophosphoryl-lipid A (MPLA) is an efficacious adjuvant for inactivated rabies vaccines","volume":"11","author":"Chen","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.mcp.2022.101833_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.mcp.2022.101833_bib13","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.vaccine.2004.10.018","article-title":"Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccine to protect cats","volume":"23","author":"Cupillard","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101833_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1099\/0022-1317-40-1-131","article-title":"Isolation and purification of a polymeric form of the glycoprotein of rabies virus","volume":"40","author":"Dietzschold","year":"1978","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.mcp.2022.101833_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/CVI.00030-11","article-title":"A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates","volume":"18","author":"Dupuy","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.mcp.2022.101833_bib16","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/infdis\/jiz645","article-title":"Serologic response of 2 versus 3 doses and intradermal versus intramuscular administration of a licensed rabies vaccine for preexposure prophylaxis","volume":"221","author":"Endy","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mcp.2022.101833_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1749-6632.1995.tb44733.x","article-title":"Plasmid vectors as anti-viral vaccines","volume":"772","author":"Ertl","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mcp.2022.101833_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1517\/14712598.3.4.639","article-title":"Rabies DNA vaccines for protection and therapeutic treatment","volume":"3","author":"Ertl","year":"2003","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.mcp.2022.101833_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.20506\/rst.37.2.2830","article-title":"Human immune responses to traditional and novel rabies vaccines","volume":"37","author":"Ertl","year":"2018","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.mcp.2022.101833_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1099\/0022-1317-59-1-197","article-title":"A single-radial-immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies","volume":"59","author":"Ferguson","year":"1982","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.mcp.2022.101833_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0092-1157(84)80008-6","article-title":"A collaborative study on the use of single radial immunodiffusion for the assay of rabies virus glycoprotein","volume":"12","author":"Ferguson","year":"1984","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.mcp.2022.101833_bib22","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/S0264-410X(03)00504-8","article-title":"Rabies DNA vaccine in the horse: strategies to improve serological responses","volume":"21","author":"Fischer","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101833_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrmicro.2018.11","article-title":"The spread and evolution of rabies virus: conquering new frontiers","volume":"16","author":"Fisher","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.mcp.2022.101833_bib24","first-page":"73","article-title":"Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine","volume":"64","author":"Fitzgerald","year":"1986","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.mcp.2022.101833_bib25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fimmu.2013.00354","article-title":"Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants","volume":"4","author":"Flingai","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcp.2022.101833_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2567.2002.01452.x","article-title":"Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses","volume":"107","author":"Forconi","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.mcp.2022.101833_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00226-17","article-title":"Antibody preparations from human transchromosomic cows exhibit prophylactic and therapeutic efficacy against Venezuelan equine encephalitis virus","volume":"91","author":"Gardner","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.mcp.2022.101833_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2020.01.006","article-title":"DNA vaccines: prime time is now","volume":"65","author":"Gary","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.mcp.2022.101833_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1586\/14760584.2015.1011134","article-title":"30 Years of rabies vaccination with Rabipur: a summary of clinical data and global experience","volume":"14","author":"Giesen","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.mcp.2022.101833_bib30","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/nar\/gki376","article-title":"JCat: a novel tool to adapt codon usage of a target gene to its potential expression host","volume":"33","author":"Grote","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcp.2022.101833_bib31","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1016\/j.vaccine.2016.04.077","article-title":"A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation","volume":"34","author":"Hannaman","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101833_bib32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CVI.00034-13","article-title":"A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis","volume":"20","author":"Hartwig","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.mcp.2022.101833_bib33","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.3390\/ijms19113605","article-title":"DNA vaccines-how far from clinical use?","volume":"19","author":"Hobernik","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcp.2022.101833_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/vaccines8030377","article-title":"A phase 2a randomized, double-blind, dose-optimizing study to evaluate the immunogenicity and safety of a bivalent DNA vaccine for hemorrhagic fever with renal syndrome delivered by intramuscular electroporation","volume":"8","author":"Hooper","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.mcp.2022.101833_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/v13030382","article-title":"Multivalent DNA vaccines as A strategy to combat multiple concurrent epidemics: mosquito-borne and hemorrhagic fever viruses","volume":"13","author":"Jiang","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.mcp.2022.101833_bib36","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(22)00151-9","article-title":"Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India","volume":"399","author":"Khobragade","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.mcp.2022.101833_bib37","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2567.2007.02560.x","article-title":"The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes","volume":"121","author":"Korsholm","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.mcp.2022.101833_bib38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/v14020401","article-title":"mRNA vaccine development for emerging animal and zoonotic diseases","volume":"14","author":"Le","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.mcp.2022.101833_bib39","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1073\/pnas.1309390110","article-title":"Immunosignatures can predict vaccine efficacy","volume":"110","author":"Legutki","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcp.2022.101833_bib40","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/21645515.2015.1010871","article-title":"Intradermal vaccination using the novel microneedle device MicronJet600: past, present, and future","volume":"11","author":"Levin","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.mcp.2022.101833_bib41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14760584.2016.1124762","article-title":"Molecular mechanisms for enhanced DNA vaccine immunogenicity","volume":"15","author":"Li","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.mcp.2022.101833_bib42","first-page":"138","article-title":"Rabbit anti-rabies immunoglobulins production and evaluation","volume":"28","author":"Liu","year":"2011","journal-title":"Trop. Biomed."},{"key":"10.1016\/j.mcp.2022.101833_bib43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm0898-949","article-title":"DNA immunization protects nonhuman primates against rabies virus","volume":"4","author":"Lodmell","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcp.2022.101833_bib44","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0264-410X(01)00392-9","article-title":"One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination","volume":"20","author":"Lodmell","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101833_bib45","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0264-410X(02)00143-3","article-title":"Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers","volume":"20","author":"Lodmell","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101833_bib46","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1016\/S0264-410X(03)00297-4","article-title":"Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody","volume":"21","author":"Lodmell","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101833_bib47","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2005.08.003","article-title":"One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus","volume":"24","author":"Lodmell","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101833_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2460\/javma.256.2.195","article-title":"Public veterinary medicine: public Health: rabies surveillance in the United States during 2018","volume":"256","author":"Ma","year":"2020","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.mcp.2022.101833_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2020.105610","article-title":"A preliminary evaluation of a locally produced biotinylated polyclonal anti-rabies antibody for direct rapid immunohistochemical test (DRIT) in the Philippines","volume":"211","author":"Manalo","year":"2020","journal-title":"Acta Trop."},{"key":"10.1016\/j.mcp.2022.101833_bib50","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.molmed.2014.09.003","article-title":"A critical analysis of codon optimization in human therapeutics","volume":"20","author":"Mauro","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.mcp.2022.101833_bib51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jcla.20275","article-title":"First production of fluorescent anti-ribonucleoproteins conjugate for diagnostic of rabies in Brazil","volume":"23","author":"Medeiros Caporale","year":"2009","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.mcp.2022.101833_bib52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.biologicals.2005.06.005","article-title":"The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays","volume":"33","author":"Moore","year":"2005","journal-title":"Biologicals"},{"key":"10.1016\/j.mcp.2022.101833_bib53","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1371\/journal.pntd.0000595","article-title":"Rabies-specific antibodies: measuring surrogates of protection against a fatal disease","volume":"4","author":"Moore","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.mcp.2022.101833_bib54","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.vaccine.2016.12.039","article-title":"Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - results of an international collaborative study","volume":"35","author":"Morgeaux","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101833_bib55","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/S0264-410X(03)00036-7","article-title":"A comparison of DNA vaccines for the rabies-related virus","volume":"21","author":"Nel","year":"2003","journal-title":"Mokola. Vaccine"},{"key":"10.1016\/j.mcp.2022.101833_bib56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13028-017-0332-x","article-title":"Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2","volume":"59","author":"Nokireki","year":"2017","journal-title":"Acta Vet. Scand."},{"key":"10.1016\/j.mcp.2022.101833_bib57","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0264-410X(98)00328-4","article-title":"Immunization of dogs and cats with a DNA vaccine against rabies virus","volume":"17","author":"Osorio","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101833_bib58","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3389\/fmicb.2020.00832","article-title":"Anti-HFRS human IgG produced in transchromosomic bovines has potent hantavirus neutralizing activity and is protective in animal models","volume":"11","author":"Perley","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.mcp.2022.101833_bib59","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0264-410X(99)00247-9","article-title":"Immunization of dogs with a DNA vaccine induces protection against rabies virus","volume":"18","author":"Perrin","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101833_bib60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000053998","article-title":"DNA-based immunization against Lyssaviruses","volume":"43","author":"Perrin","year":"2000","journal-title":"Intervirology"},{"key":"10.1016\/j.mcp.2022.101833_bib61","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biologicals.2019.03.002","article-title":"A new recombinant rabies virus expressing a green fluorescent protein: a novel and fast approach to quantify virus neutralizing antibodies","volume":"59","author":"Qin","year":"2019","journal-title":"Biologicals"},{"key":"10.1016\/j.mcp.2022.101833_bib62","first-page":"207","article-title":"Development of rabies DNA vaccine using a recombinant plasmid","volume":"49","author":"Rai","year":"2005","journal-title":"Acta Virol."},{"key":"10.1016\/j.mcp.2022.101833_bib63","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-1-0716-0872-2_17","article-title":"Ethics of DNA vaccine transfer for clinical research","volume":"2197","author":"Ramalhinho","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.mcp.2022.101833_bib64","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1586\/erv.09.77","article-title":"DNA vaccines in veterinary use","volume":"8","author":"Redding","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.mcp.2022.101833_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cimid.2007.11.004","article-title":"Ovine anti-rabies antibody production and evaluation","volume":"32","author":"Redwan el","year":"2009","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.mcp.2022.101833_bib66","doi-asserted-by":"crossref","first-page":"S658","DOI":"10.1093\/infdis\/jiy430","article-title":"Human polyclonal antibodies produced by transchromosomal cattle provide partial protection against lethal zaire ebolavirus challenge in rhesus macaques","volume":"218","author":"Rosenke","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mcp.2022.101833_bib67","first-page":"63","article-title":"The 3Rs and animal welfare - conflict or the way forward?","volume":"20","author":"Rusche","year":"2003","journal-title":"ALTEX"},{"key":"10.1016\/j.mcp.2022.101833_bib68","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2013.12.020","article-title":"DNA vaccines for HFRS: laboratory and clinical studies","volume":"187","author":"Schmaljohn","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.mcp.2022.101833_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.786953","article-title":"Lyssaviruses and the fatal encephalitic disease rabies","volume":"12","author":"Scott","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcp.2022.101833_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96884-6","article-title":"Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster model","volume":"11","author":"Sroga","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcp.2022.101833_bib71","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tmaid.2007.07.004","article-title":"Preventing rabies with the Verorab vaccine: 1985-2005 Twenty years of clinical experience","volume":"5","author":"Toovey","year":"2007","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.mcp.2022.101833_bib72","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.PLAS-0028-2014","article-title":"Using plasmids as DNA vaccines for infectious diseases","volume":"2","author":"Tregoning","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.mcp.2022.101833_bib73","first-page":"447","article-title":"Production of rabies fluorescent conjugate by immunization of rabbits with purified rabies antigen","volume":"51","author":"Trimarchi","year":"1974","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.mcp.2022.101833_bib74","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1128\/JVI.76.20.10540-10545.2002","article-title":"Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant","volume":"76","author":"van Rooij","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.mcp.2022.101833_bib75","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0092-1157(89)90030-9","article-title":"A modification of the single radial immunodiffusion potency test (SRD) for rabies vaccines","volume":"17","author":"Vogel","year":"1989","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.mcp.2022.101833_bib76","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nri.2017.148","article-title":"Passive immunotherapy of viral infections: 'super-antibodies' enter the fray","volume":"18","author":"Walker","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mcp.2022.101833_bib77","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1038\/emm.2017.23","article-title":"From rabbit antibody repertoires to rabbit monoclonal antibodies","volume":"49","author":"Weber","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mcp.2022.101833_bib78","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0065-3527(01)56030-3","article-title":"DNA immunization and central nervous system viral infection","volume":"56","author":"Whitton","year":"2001","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.mcp.2022.101833_bib79","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1006\/viro.1995.1289","article-title":"Immune responses to nucleic acid vaccines to rabies virus","volume":"209","author":"Xiang","year":"1995","journal-title":"Virology"}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850822000445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850822000445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:17:31Z","timestamp":1760192251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850822000445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":79,"alternative-id":["S0890850822000445"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2022.101833","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Robust humoral immune response against rabies virus in rabbits and guinea pigs immunized with plasmid DNA vectors encoding rabies virus glycoproteins \u2013 An approach to the production of polyclonal antibody reagents","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2022.101833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101833"}}